MX2020001574A - Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda. - Google Patents

Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.

Info

Publication number
MX2020001574A
MX2020001574A MX2020001574A MX2020001574A MX2020001574A MX 2020001574 A MX2020001574 A MX 2020001574A MX 2020001574 A MX2020001574 A MX 2020001574A MX 2020001574 A MX2020001574 A MX 2020001574A MX 2020001574 A MX2020001574 A MX 2020001574A
Authority
MX
Mexico
Prior art keywords
systems
methods
control
necrosis disease
hepatopancreatic necrosis
Prior art date
Application number
MX2020001574A
Other languages
English (en)
Inventor
Richard Sayre
Tatiana Vinogradova-Shah
Elena Sineva
Original Assignee
Pebble Labs Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/025766 external-priority patent/WO2018184029A1/en
Priority claimed from PCT/US2018/033976 external-priority patent/WO2018217819A1/en
Application filed by Pebble Labs Usa Inc filed Critical Pebble Labs Usa Inc
Publication of MX2020001574A publication Critical patent/MX2020001574A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Abstract

En general, la tecnología de la invención se refiere a novedosas estrategias para el control de enfermedades en sistemas animales; específicamente, la tecnología de la invención se refiere a métodos, sistemas y composiciones novedosas para el biocontrol de patógenos en sistemas acuáticos; específicamente, la invención puede comprender técnicas, sistemas y métodos novedosos para el biocontrol de patógenos transmisores de enfermedades que afectan a los camarones en los sistemas acuícolas.
MX2020001574A 2017-08-07 2018-08-07 Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda. MX2020001574A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762541824P 2017-08-07 2017-08-07
PCT/US2018/025766 WO2018184029A1 (en) 2017-03-31 2018-04-02 Novel system for the biocontrol of pathogens in aquaculture and other animal systems
PCT/US2018/033976 WO2018217819A1 (en) 2017-05-22 2018-05-22 Transbiotic regulation of bacterial gene expression
PCT/US2018/045687 WO2019032629A1 (en) 2017-08-07 2018-08-07 SYSTEMS AND METHODS FOR FIGHTING ACUTE HEEPATOPANCREATIC NECROSIS DISEASE

Publications (1)

Publication Number Publication Date
MX2020001574A true MX2020001574A (es) 2020-09-03

Family

ID=65271567

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001574A MX2020001574A (es) 2017-08-07 2018-08-07 Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.

Country Status (9)

Country Link
US (1) US11944676B2 (es)
EP (1) EP3664616A4 (es)
CN (1) CN111433349A (es)
BR (1) BR112020002689A2 (es)
CL (1) CL2020000329A1 (es)
EC (1) ECSP20016817A (es)
MX (1) MX2020001574A (es)
SG (1) SG11202001143YA (es)
WO (1) WO2019032629A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3664616A4 (en) 2017-08-07 2021-08-11 Pebble Labs, Inc. SYSTEMS AND METHODS FOR CONTROLLING ACUTE HEPATOPANCREATIC NECROSIS DISEASE
CN110317792B (zh) * 2019-06-03 2021-05-25 台州学院 副溶血弧菌噬菌体vp-hyp2及其应用
WO2021046401A1 (en) * 2019-09-05 2021-03-11 Pebble Labs Usa, Inc. Systems, methods, and compositions for the inhibition of bacterial toxins to treat early mortality syndrome in aquatic animals
US20230233621A1 (en) * 2020-06-12 2023-07-27 Pebble Labs Inc. Novel probiotic bacteria and methods to control pathogens in aquatic animals
CN112753629B (zh) * 2020-12-30 2022-08-30 亚太海洋生物科技(厦门)有限公司 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
AU2002365928A1 (en) * 2001-10-26 2003-09-02 Princeton University Inhibitors of autoinducer transporters
US20050227933A1 (en) 2001-11-29 2005-10-13 Benkovic Stephen J Treatment of bacterial induced diseases using DNA methyl transferase inhibitors
BRPI0412282A (pt) 2003-07-02 2006-09-19 Musc Found For Res Dev imunidade especìfica e não-especìfica induzida de dsrna em crustáceos e outros invertebrados, e veìculos de bioliberação para uso nestes
US7247437B2 (en) 2003-08-21 2007-07-24 Trustees Of Tufts College Vibrionaceae replication factors and methods of use thereof
US20050158326A1 (en) 2003-12-24 2005-07-21 Chin-Yu Chen Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof
MXPA06009005A (es) 2004-02-06 2007-03-26 Advanced Bionutrition Corp Interferencia mediada por acido ribonucleico para el control de enfermedad en animales terrestres y de acuacultura.
WO2008027235A1 (en) 2006-08-25 2008-03-06 University Of New Mexico Methods and compositions for control of disease in aquaculture
CA2736885C (en) 2008-09-17 2016-12-06 Agraquest, Inc. Method for using a bacillus subtilis strain to enhance animal health
US20120107355A1 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
KR101242821B1 (ko) * 2011-01-31 2013-03-12 씨제이제일제당 (주) 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스
KR101049672B1 (ko) 2011-02-01 2011-07-14 박명진 초음파 유도하 중재적 시술용 바늘구조
GB201107768D0 (en) * 2011-05-10 2011-06-22 Univ Manchester Riboswitches
US9932598B2 (en) * 2012-08-02 2018-04-03 The Regents Of The University Of California Metabolic engineering of microbial organisms
CA2905961C (en) 2013-03-15 2023-04-25 Monsanto Technology Llc Compositions and methods for the production and delivery of rna
WO2015059690A1 (en) 2013-10-24 2015-04-30 Yeda Research And Development Co. Ltd. Polynucleotides encoding brex system polypeptides and methods of using s ame
KR20160085801A (ko) * 2013-11-04 2016-07-18 알드바크 아이피 홀딩, 엘엘씨 양식 수처리 시스템 및 방법
AU2017326616A1 (en) 2016-09-16 2019-04-04 Pebble Labs Usa Inc. Novel paratransgenic system for the biocontrol of disease-transmitting mosquitos
AU2018243858A1 (en) 2017-03-31 2019-10-10 Pebble Labs Usa Inc. Novel system for the biocontrol of pathogens in aquaculture and other animal systems
US20200149048A1 (en) 2017-05-22 2020-05-14 Pebble Labs Usa Inc. Transbiotic Regulation of Bacterial Gene Expression
EP3664616A4 (en) 2017-08-07 2021-08-11 Pebble Labs, Inc. SYSTEMS AND METHODS FOR CONTROLLING ACUTE HEPATOPANCREATIC NECROSIS DISEASE

Also Published As

Publication number Publication date
SG11202001143YA (en) 2020-03-30
CL2020000329A1 (es) 2020-08-14
BR112020002689A2 (pt) 2020-08-25
CN111433349A (zh) 2020-07-17
US20200178566A1 (en) 2020-06-11
WO2019032629A1 (en) 2019-02-14
EP3664616A1 (en) 2020-06-17
US11944676B2 (en) 2024-04-02
EP3664616A4 (en) 2021-08-11
ECSP20016817A (es) 2020-04-22

Similar Documents

Publication Publication Date Title
MX2020001574A (es) Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.
MX2020001683A (es) Mezclas agricolas.
SG11201804078QA (en) Aquaponics system, and fish and shellfish rearing and plant cultivation method using the aquaponics system
PH12019502214A1 (en) Novel system for the biocontrol of pathogens in aquaculture and other animal systems
MX2017008813A (es) Polvo de coleopteros.
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MX2017008815A (es) Composicion que contiene quitina y proteinas digeribles.
PH12018500379A1 (en) Biopharmaceutical compositions
MX2016014144A (es) Composiciones de proteina concentrada y metodos para su elaboracion y uso.
PH12018500762A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
MX2016014147A (es) Composiciones de proteina soluble y metodos para su elaboracion.
MX2016014145A (es) Composiciones de proteina con tamaño de particula pequeño y metodos para elaborarlas.
MX2019008546A (es) Usos terapeuticos de un polvo de insectos.
MX2018015410A (es) Esteres de oxaborol y sus usos.
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
MX2015014121A (es) Producto alimenticio y/o ingrediente alimenticio.
MX370581B (es) Metodo mejorado de cultivo de ostras.
WO2017029558A3 (en) Methods for improving health of farmed fish
WO2019016597A3 (en) SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES
WO2015185993A9 (en) Methods for improving fillet quality in farmed fish
WO2018035199A8 (en) Sea lice vaccine
MX2021015922A (es) Proteínas quiméricas sintéticas estabilizadas y sus usos terapéuticos.
EA202090997A1 (ru) Усовершенствованная подводная промысловая система